AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$AMRZ

Forrest Nollaig purchased $66K of AMRZ

Forrest Nollaig (Chief Mktg & Corp Affairs Off) purchased 1,500 shares of Amrize Ltd (AMRZ) at $44.15 on 2026-08-25.

Original reporting
SEC EDGAR · Forrest Nollaig
Published Aug 25, 2026, 7:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AMRZ
Neutral
medium confidence
Mentioned
$AMRZ
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMRZNeutralLow
01

Why it matters

The purchase adds modest ownership for the officer but is unlikely to affect market perception.

02

Market read

Low relevance; the transaction size is small and does not suggest immediate price movement.

03

What to watch

Potential upcoming marketing initiatives not disclosed.

Relevance 4/10Novelty 5/10Timing: today

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the purchase.

Company-level read

Ticker impact

$AMRZNeutralMedium confidence
Context

Chief Marketing Officer Forrest Nollaig bought 1,500 shares at $44.15, total $66,225, increasing his stake to 21,639 shares.

Expected impact

minimal impact

Evidence & confidence

Purchase size is modest relative to market cap and represents a routine 10b5‑1‑free transaction.

Market effects

Sector

None; insider activity does not affect sector trends.

Regional

None; transaction is company‑specific.

Global

None; limited to Amrize Ltd.

Counterpoint

What could challenge this read

Even small insider buys can signal confidence; monitor for future purchases.

Key entities

  • Company
    Amrize Ltd

    Issuer of the Form 4 filing.

  • Insider
    Forrest Nollaig

    Chief Marketing & Corporate Affairs Officer.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AMRZ insider trading history →

Related articles

AUG 14
$AMRZMedAI 8/10

Amrize (AMRZ) Q2 2026 Earnings Call Transcript

Amrize AG (AMRZ) reported Q2 2026 revenue of $3.49B, up 8.6%, and net income of $476M, up 14.4%, with adjusted EBITDA of $986M. Management raised fiscal 2026 revenue guidance to $12.5B-$12.7B but revised adjusted EBITDA to $3.1B-$3.2B due to oil-driven cost inflation. The company cited data center and infrastructure demand.

fool.com6 min
AUG 10
$AMRZMedAI 8/10

Amrize Q2 EPS misses $0.94 estimate as costs weigh on margins

Amrize (NYSE: AMRZ) reported Q2 2026 adjusted EPS of $0.88, below the $0.94 consensus estimate. Revenue rose 8.51% to $3.494 billion, beating the $3.365 billion expectation. Net income increased 14.4% to $476 million. The company raised FY2026 revenue guidance to $12.5B-$12.7B but lowered adjusted EBITDA guidance to $3.1B-$3.2B due to cost inflation.

scanx.trade6 min
AUG 10
$AMRZMed

RBC Downgrades Amrize After A Rare Q2 Miss

RBC downgraded Amrize after a rare Q2 miss and reduced guidance, citing a timing mismatch between input-cost increases and the full pass-through of surcharges and price hikes. RBC cut 2026-2028 EBITDA estimates by 4%, 6%, and 7% and EPS by 12%, 14%, and 15%, lowering its stock rating to underperform and price target to $48 from $60.

finimize.com4 min